In this issue of Dermatology Times, experts weigh in on how AI can improve clinical practice and quality of life - but only if doctors are involved in the development of new technology. The issue also covers advances in acne therapy and melanoma treatment, and highlights the professional accomplishments of champions in the specialty from the past 40 years.
 
Dermatology Times cover
Should dermatologists embrace AI?
Allan C. Halpern, M.D., discusses what dermatologists need to understand about AI and how it might interact with or disrupt the specialty.
40 years of champions in dermatology
In the decades that Dermatology Times reporters have covered the specialty, we’ve had the pleasure of profiling the specialty’s champions. Some shared their professional accomplishments, while others revealed unknown aspects of their personal lives. Here just some of the interesting tidbits from years’ past.
FDA approves novel topical retinoid trifarotene for acne
The U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.
Nanovaccine shows promise for melanoma
A novel nanovaccine has demonstrated efficacy in preventing the development of melanoma in mouse models, according to a recent study.

Connect with us on Twitter and Facebook for daily updates.